Patient reminder card on the safe use of the medicinal product ROACCUTANE® (isotretinoin), risk of teratogenicity and birth defects

30.09.2025 720 views

Patient reminder card on the safe use of the medicinal product ROACCUTANE® (isotretinoin), risk of teratogenicity and congenital malformationsPDF · 1.5 MB

Download

Patient reminder card on the safe use of the medicinal product ROACCUTANE® (isotretinoin), risk of teratogenicity and birth defects

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Patient reminder card on the safe use of the medicinal product ROACCUTANE® (isotretinoin), risk of teratogenicity and birth defects

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration